Cargando…

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway

Researchers have reported that zinc finger CCHC domain containing 12 gene (ZCCHC12) plays a role in the progression and tumorigenesis of papillary thyroid cancer. However, the biological role of ZCCHC12 in osteosarcoma (OS) remains unknown. ZCCHC12 was highly upregulated in OS cell lines according t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yong, Dong, Yong-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550259/ https://www.ncbi.nlm.nih.gov/pubmed/36126191 http://dx.doi.org/10.18632/aging.204296

Ejemplares similares

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway
por: Ma, Kun, et al.
Publicado: (2022)

TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation
por: Ma, Kun, et al.
Publicado: (2020)

Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
por: Zhang, Yong, et al.
Publicado: (2020)

STEAP2 promotes osteosarcoma progression by inducing epithelial–mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2
por: Zhang, Dong, et al.
Publicado: (2022)

Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling
por: Doppelt-Flikshtain, Ofri, et al.
Publicado: (2023)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Calycosin induces apoptosis in osteosarcoma cell line via ERβ-mediated PI3K/Akt signaling pathways
por: Tian, Wei, et al.
Publicado: (2020)

Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
por: Sim, IlJin, et al.
Publicado: (2023)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

LncRNA TDRG1 Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transformation of Osteosarcoma Through PI3K/AKT Signal Pathway
por: Huang, Yan, et al.
Publicado: (2020)

LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway
por: Tong, Chang-Jun, et al.
Publicado: (2021)

Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma
por: Zhang, Kexiang, et al.
Publicado: (2021)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway
por: Yu, Guangyang, et al.
Publicado: (2018)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

β-Escin inhibits the proliferation of osteosarcoma cells via blocking the PI3K/Akt pathway
por: Zhu, Minyu, et al.
Publicado: (2018)

AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway
por: Wu, Xuan, et al.
Publicado: (2022)

RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
por: Wei, Zhun, et al.
Publicado: (2023)

Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway
por: Zhang, Dong, et al.
Publicado: (2017)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
por: Jiang, Liang, et al.
Publicado: (2017)

Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression
por: Zhang, Zhenhao, et al.
Publicado: (2023)

LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway
por: Wang, Danfang, et al.
Publicado: (2022)

Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway
por: Xu, Chaojian, et al.
Publicado: (2022)

DPY30 promotes the growth and survival of osteosarcoma cells by regulating the PI3K/AKT signal pathway
por: Cheng, Gong, et al.
Publicado: (2022)

Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
por: Liu, Bing, et al.
Publicado: (2017)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

PLEKHG2 Promotes NSCLC Cell Growth by Increasing Glycolysis via Activated PI3K/AKT Pathway
por: Xia, Yang, et al.
Publicado: (2023)

Melatonin Stimulates STAR Expression and Progesterone Production via Activation of the PI3K/AKT Pathway in Bovine Theca Cells
por: Wang, Xiaomei, et al.
Publicado: (2019)

Sema4D/Plexin-B1 promotes the progression of osteosarcoma cells by activating Pyk2-PI3K-AKT pathway
por: Li, Changhui, et al.
Publicado: (2021)

Selective microRNA uridylation by Zcchc6 (TUT7) and Zcchc11 (TUT4)
por: Thornton, James E., et al.
Publicado: (2014)

Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS
por: Yuan, Xuhui, et al.
Publicado: (2023)

LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway
por: Qi, Fei, et al.
Publicado: (2023)

Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway
por: Lin, Hong, et al.
Publicado: (2022)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2020)

CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021)

SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway
por: Xu, Liyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ca5bues2uujn98qpnimshrjr49